ResMed Downgraded by CIMB to Hold (RMD)
ResMed (NYSE:RMD) was downgraded by equities researchers at CIMB to a “hold” rating in a research report issued on Monday, AnalystRatingsNetwork.com reports.
A number of other analysts have also recently weighed in on RMD. Analysts at Canaccord Genuity cut their price target on shares of ResMed from $49.00 to $43.00 in a research note to investors on Friday. They now have a “hold” rating on the stock. Separately, analysts at William Blair downgraded shares of ResMed from an “outperform” rating to a “market perform” rating in a research note to investors on Friday. Finally, analysts at Jefferies Group cut their price target on shares of ResMed from $46.00 to $40.00 in a research note to investors on Friday. Ten analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $48.05.
Shares of ResMed (NYSE:RMD) traded down 0.16% on Monday, hitting $43.81. The stock had a trading volume of 1,681,070 shares. ResMed has a 52-week low of $41.98 and a 52-week high of $57.34. The stock’s 50-day moving average is $46.56 and its 200-day moving average is $49.38. The company has a market cap of $6.225 billion and a P/E ratio of 20.22.
ResMed (NYSE:RMD) last released its earnings data on Thursday, January 23rd. The company reported $0.60 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.63 by $0.03. The company had revenue of $384.30 million for the quarter, compared to the consensus estimate of $398.09 million. During the same quarter last year, the company posted $0.53 earnings per share. ResMed’s revenue was up 2.1% compared to the same quarter last year. Analysts expect that ResMed will post $2.57 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Wednesday, March 19th. Shareholders of record on Wednesday, February 19th will be given a dividend of 0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 2.28%. The ex-dividend date of this dividend is Friday, February 14th.
ResMed Inc, (NYSE:RMD) is a holding company for the ResMed Group.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.